These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16702215)
1. In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase. Kovaleski BJ; Kennedy R; Hong MK; Datta SA; Kleiman L; Rein A; Musier-Forsyth K J Biol Chem; 2006 Jul; 281(28):19449-56. PubMed ID: 16702215 [TBL] [Abstract][Full Text] [Related]
2. Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase. Kovaleski BJ; Kennedy R; Khorchid A; Kleiman L; Matsuo H; Musier-Forsyth K J Biol Chem; 2007 Nov; 282(44):32274-9. PubMed ID: 17724017 [TBL] [Abstract][Full Text] [Related]
3. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. Javanbakht H; Halwani R; Cen S; Saadatmand J; Musier-Forsyth K; Gottlinger H; Kleiman L J Biol Chem; 2003 Jul; 278(30):27644-51. PubMed ID: 12756246 [TBL] [Abstract][Full Text] [Related]
4. Association of mitochondrial Lysyl-tRNA synthetase with HIV-1 GagPol involves catalytic domain of the synthetase and transframe and integrase domains of Pol. Kobbi L; Octobre G; Dias J; Comisso M; Mirande M J Mol Biol; 2011 Jul; 410(5):875-86. PubMed ID: 21763493 [TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly. Halwani R; Cen S; Javanbakht H; Saadatmand J; Kim S; Shiba K; Kleiman L J Virol; 2004 Jul; 78(14):7553-64. PubMed ID: 15220430 [TBL] [Abstract][Full Text] [Related]
6. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex. Saadatmand J; Guo F; Cen S; Niu M; Kleiman L Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237 [TBL] [Abstract][Full Text] [Related]
7. Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1. Dewan V; Wei M; Kleiman L; Musier-Forsyth K J Biol Chem; 2012 Dec; 287(50):41955-62. PubMed ID: 23095741 [TBL] [Abstract][Full Text] [Related]
8. Determinants of the interaction between the 5'-leader of HIV-1 genome and human lysyl-tRNA synthetase in reverse transcription primer release process. Liu Y; Luo Z; Chen X; Yang X; Qi Q; Alifu M; Tao C; Cui W; Liu M; Wang W Biochem Biophys Res Commun; 2024 Sep; 725():150252. PubMed ID: 38878758 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 Exploits a Dynamic Multi-aminoacyl-tRNA Synthetase Complex To Enhance Viral Replication. Duchon AA; St Gelais C; Titkemeier N; Hatterschide J; Wu L; Musier-Forsyth K J Virol; 2017 Nov; 91(21):. PubMed ID: 28814526 [TBL] [Abstract][Full Text] [Related]
10. Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein. Boonyalai N; Pullen JR; Abdul Wahab MF; Wright M; Miller AD Org Biomol Chem; 2013 Jan; 11(4):612-20. PubMed ID: 23208549 [TBL] [Abstract][Full Text] [Related]
11. Phosphomimetic S207D Lysyl-tRNA Synthetase Binds HIV-1 5'UTR in an Open Conformation and Increases RNA Dynamics. Cantara WA; Pathirage C; Hatterschide J; Olson ED; Musier-Forsyth K Viruses; 2022 Jul; 14(7):. PubMed ID: 35891536 [TBL] [Abstract][Full Text] [Related]
12. The tRNALys packaging complex in HIV-1. Kleiman L; Cen S Int J Biochem Cell Biol; 2004 Sep; 36(9):1776-86. PubMed ID: 15183344 [TBL] [Abstract][Full Text] [Related]
13. Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. Cen S; Khorchid A; Javanbakht H; Gabor J; Stello T; Shiba K; Musier-Forsyth K; Kleiman L J Virol; 2001 Jun; 75(11):5043-8. PubMed ID: 11333884 [TBL] [Abstract][Full Text] [Related]
14. The selective packaging and annealing of primer tRNALys3 in HIV-1. Kleiman L; Halwani R; Javanbakht H Curr HIV Res; 2004 Apr; 2(2):163-75. PubMed ID: 15078180 [TBL] [Abstract][Full Text] [Related]
15. Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1. Cen S; Javanbakht H; Niu M; Kleiman L J Virol; 2004 Feb; 78(3):1595-601. PubMed ID: 14722314 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cellular HIV-1 protease activity by lysyl-tRNA synthetase. Guo F; Gabor J; Cen S; Hu K; Mouland AJ; Kleiman L J Biol Chem; 2005 Jul; 280(28):26018-23. PubMed ID: 15888436 [TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing. Jones CP; Saadatmand J; Kleiman L; Musier-Forsyth K RNA; 2013 Feb; 19(2):219-29. PubMed ID: 23264568 [TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1. Guo F; Cen S; Niu M; Javanbakht H; Kleiman L J Virol; 2003 Sep; 77(18):9817-22. PubMed ID: 12941890 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site. Na Nakorn P; Treesuwan W; Choowongkomon K; Hannongbua S; Boonyalai N J Theor Biol; 2011 Feb; 270(1):88-97. PubMed ID: 21093454 [TBL] [Abstract][Full Text] [Related]
20. Effect of Lysyl-tRNA Synthetase on the Maturation of HIV-1 Reverse Transcriptase. Ilina TV; Slack RL; Guerrero M; Ishima R ACS Omega; 2020 Jul; 5(27):16619-16627. PubMed ID: 32685828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]